Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT02115295
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01746836
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03630991
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04188405
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Crisis, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT04681105
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT01904136
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Gene Mutations, +26 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01823198
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02311998
- Conditions
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01822509
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT01527045
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00105001
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
Active, Not Recruiting
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02861417
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States